Industry News
New study to explore genetics of eczema
A tri-state research collaboration is set to use sibling pairs to examine the genetic reasoning behind the most common form of eczema [ + ]
CSIRO livestock researchers explore potential of new technologies
Two animal-virus hunters at CSIRO are exploring the potential of advanced genetic and proteomics technologies to make more accurate and rapid diagnoses of viral diseases and other microbial infections of livestock. [ + ]
Virax raises $3.4m
Development-stage biotechnology company Virax Holdings (ASX: VHL) has raised $3.4 million in a capital raising aimed to progress its prostate cancer and HIV drug development programs. [ + ]
New CEO at Peplin Biotech
Brisbane small molecule drug development company Peplin Biotech (ASX: PEP) today announced the appointment of its new chief executive. [ + ]
Burying the problem of greenhouse emissions
More than half of Australia's carbon dioxide emissions come from power stations. Storing these harmful gases underground can drastically reduce the rate of emission build-up in our atmosphere.
[ + ]History offers modern slant on bioethics
University of Queensalnd historian Dr Sarah Ferber is redefining contemporary bioethics to include a historical dimension. And she's planning a book exploring topics such as medicine and social morality, human experimentation, women and reproductive medicine, genetic research and euthanasia.
[ + ]WEHI team exposes two new anti-cancer targets
Cancer researchers in Melbourne and Innsbruck hunting for new options to treat cancer have flushed two promising new therapeutic targets from the genetic thickets of the p53-mediated apoptosis pathway: Puma and Noxa. [ + ]
Hunter research labs team with Amersham in new project
The University of Newcastle and the Hunter Medical Research Institute have linked up with international life sciences supply company Amersham BioSciences to establish a sophisticated analytical laboratory for research into personalised medicine. [ + ]
Diabetes researcher Zimmett honoured
Diabetes luminary Prof Paul Zimmet has been honoured by his peers, receiving the Kellion Award for his contribution to the field. [ + ]
pSivida claims success in anti-tumour device study
A nano-structured silicon device containing slow-release radiotherapy has successfully halted tumours in an animal study. [ + ]
Cardia spin-off slated for funds, IPO
Research into a promising new anti-diabetes compound derived from tree bark will receive a major funding boost under a heads of agreement deal brokered in Melbourne this week. [ + ]
Progen raises $9.6m in share placement
Small molecule drug company Progen Industries (ASX:PGL, Nasdaq:PGLAF) has doubled its cash reserves in a share placement aimed to help the Brisbane biotech expand its product pipeline. [ + ]
Starpharma teams with IDT, AGT to test and develop drugs
It has been a week for collaborations at the Melbourne-based polyvalent nanotechnology development company, Starpharma (ASX:SPL). [ + ]
SA researchers to have better access to equipment, expertise
A new South Australian initiative aims to give scientists in that state easier access to expensive research equipment and expertise. [ + ]
Benitec appoints RNAi specialist to head US advisory board
Brisbane gene silencing company Benitec (ASX:BLT) has appointed a specialist in DNA-directed RNA interference to chair its scientific advisory board in the United States. [ + ]
